RAD51C and PALB2 deficient patients shared the BRCA2-type HRD phenotype (absence of duplications) with BRCA2 deficient patients (clusters 1–3; Fig. 3c), consistent with previous studies11,12. The gene discussed is BRCA2; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.